Exclusivity Provision Surfaces In OTC Monograph Bill
This article was originally published in The Pink Sheet
Executive Summary
The House Health subcommittee asks whether allowing manufacturers' periods of US market exclusivity for some approved OTC monograph proposals is needed, or would be fair to consumers.